Ernexa Therapeutics (ERNAW) FCF Margin Growth (1y) (2011 - 2024)
Ernexa Therapeutics (ERNAW) FCF Margin Growth (1y) (2011 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
5,389.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,525.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Ernexa Therapeutics |
- |
- |
- |
- |
| Date | Value |
|---|
| Dec 31, 2024 |
-910,687.00 |
| Sep 30, 2024 |
1.01 Mn |
| Dec 31, 2020 |
-16,009.00 |
| Sep 30, 2020 |
-16,508.00 |
| Mar 31, 2020 |
-8,722.00 |
| Dec 31, 2019 |
1,462.00 |
| Sep 30, 2019 |
-72.00 |
| Jun 30, 2019 |
27.00 |
| Mar 31, 2019 |
1,440.00 |
| Dec 31, 2018 |
1,068.00 |
| Sep 30, 2018 |
4,203.00 |
| Jun 30, 2018 |
-5,019.00 |
| Mar 31, 2018 |
621.00 |
| Dec 31, 2017 |
-958.00 |
| Sep 30, 2017 |
-3,347.00 |
| Jun 30, 2017 |
4,703.00 |
| Mar 31, 2017 |
197.00 |
| Dec 31, 2016 |
2,953.00 |
| Sep 30, 2016 |
2,944.00 |
| Jun 30, 2016 |
4,615.00 |
